Document:

NÚMERO DE REGISTRO: AQUÍ YA SE MENCIONA UN NUMERO DE CONVENIO

REGISTRATION NUMBER: 

29495-1575-10-VIII-11

THIS IS A JOINT-VENTURE AGREEMENT REACHED BY LA UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO (IN ENGLISH, “THE NATIONAL AUTONOMOUS UNIVERSITY OF MEXICO”), HEREINAFTER CALLED “LA UNAM”, REPRESENTED IN THIS ACTION BY ITS SECRETARY GENERAL, DR. EDUARDO BÁRZANA GARCÍA, WITH THE DIRECTOR OF THE VETERINARY MEDICINE SCHOOL, DR. FRANCISCO JOSÉ TRIGO TAVERA, AND THE ACADEMICIAN AND RESEARCHER OF THE CENTER FOR TRAINING, RESEARCH Y EXPANSION OF HIGH PLATEAU ANIMAL PRODUCTION OF THE VETERINARY MEDICINE SCHOOL, DR. GILBERTO CHÁVEZ GRIS, IN ATTENDANCE; AND APPLIED GENETICS, S. A. DE C. V. (IN ENGLISH, “PUBLIC-JOINT-STOCK-COMPANY”), HEREINAFTER CALLED “APPLIED”, REPRESENTED IN THIS ACTION BY ITS DIRECTOR GENERAL, Dr. ANTONIO MILICI, IN ACCORDANCE WITH THE FOLLOWING TERMS AND PROVISIONS:  

DECLARATIONS

I.

“LA UNAM” DECLARES: 

1.                                                                                                                        

That in accordance with Article 1 of its Constitution it is a publicly-owned corporation, a decentralized sub-division of the State endowed with full legal capacity that has the goal of imparting higher education and developing professionals, researchers, university professors, and technicians to serve society, as well as to organize and conduct research, primarily pertaining to the national conditions and problems, and to extend to the highest attainable extent the benefits of the culture.   

2.                                                                                                                        

That the legal representation of this research institution, in accordance with what is set forth in Articles 9 of its Constitution and 30 of its General Statute, is the responsibility of its Rector, Dr. José Narro Robles, who, pursuant to section I of Article 34 of the same Statute, has the ability to delegate the same.   

3.                                                                                                                        

That Dr. Eduardo Bárzana García, in his role as Secretary General, is authorized to sign this Agreement, pursuant to the applicable provisions in the agreement that delegate and distribute responsibilities for the signing of pacts, agreements, contracts, and other consensual instruments of which the University would be a part, published in the UNAM Gazette on January 23, 2003. 

4.                                                                                                                        

That the Veterinary Medicine School, whose chief is Dr. Francisco José Trigo Tavera, is within the University’s constitutional-academic structure, and has the necessary infrastructure and resources to fulfill the goals of this pact. 

5.                                                                                                                        

That, for the purpose of complying with this agreement, it specifies its physical domicile that which is located at the Center for Training, Research, and Expansion of High Plateau Animal Production of the Veterinary Medicine School (C.E.I.E.P.A.A.) in the School of Veterinary Medicine: Km 8.5, Carretera Tequisquiapan-Ezequiel Montes, Tequisquiapan, Querétaro.

6.                                                                                                                        

That, for the purposes of this instrument, it specifies its legal domicile that which is located on the 9th floor of the Rectory Building, Ciudad Universitaria, Delegación Coyoacán, México, Distrito Federal, C. P. 04510.

I.

“APPLIED” DECLARES:

1.

That it is a Public-Joint-Stock-Company, legally formed in conformity with the laws of Mexico, as confirmed in the Public Registry Number 18,972, dated September 28, 2007, granted before Notary Public Number 85 in the State of Nuevo León, Honorable Enrique Morales Montemayor, and entered into the Public Registry for Property and Commercial Transactions at Commercial Page Number 105866-1, Characters as to the  authenticity of the inscription: 7161fol4d90c.12cf ́l5863c8f9flt70d177cd02c, on the 19th day of October, 2008.

1.

That it has as its goal the development of molecular trials for the diagnosis of animal illnesses, as well as the detection of infectious pathogens in food, the development of genetically modified organisms, the fulfillment of all of the actions execution of all of the contracts that are related to said branch. 

2.

That Dr. Antonio Milici, in his capacity as its President, possesses the necessary authority to sign this instrument as such authority was given to him pursuant to the granting of such powers in Article Seventeen of the Public Registry Number 18,972, dated September 28, 2007, before Notary Public 85 in the State of Nuevo León, Lic. Enrique Morales Montemayor.

3.

That its legal domicile is located at 173 Avenida Mundial, Parque Industrial JM, en el Municipio de Apodaca, Nuevo León C.P. 66600.

II.

BOTH PARTIES DECLARE: 

That, having expounded all of the above, they are both amenable to subject their commitment in accordance with the following: 

 

CLAUSES

FIRST: OBJECTIVE

The purpose of this pact is the collaboration between the parties hereto with the goal of conducting a research Project called: “VALIDATION OF A MOLECULAR SYSTEM VIA PCR IN REAL TIME, TO DETECT THE PRESENCE OF MYCOBACTERIUM PARATUBERCULOSIS EN RUMIANTES”. (BOVINES, OVINES Y CAPRINES).

 

SECOND. “LA UNAM’S” COMMITMENTS 

To facilitate the successful execution of the material objectives of this agreement, “LA UNAM” commits itself to:

a.

Adapt or make suitable the number of samples subject to the protocol, which will include from 100 to 200 blood samples taken from infected animals (bovines, ovines y caprines) and utilized during the course of the research to be conducted. 

b.

Develop research, diagnostic testing procedures, and the validation of tests in different studies of Johne’s Syndrome en the laboratory located at the Training, Research, and Expansion of High Plateau Animal Production Center (C.E.I.E.P.A.A.) of the Veterinary Medicine School.

c.

Provide to “APPLIED”, located in Ciudad De Apodaca, Nuevo León, Méjico, samples that are homologous to the samples that will be received by the laboratory at the Training, Research, and Expansion of High Plateau Animal Production Center (C.E.I.E.P.A.A.). 

d.

Grant access and facilities to the clinical trials that will be effectuated during the research project, as long as it is in writing so as to not interfere with other activities that are being effectuated at that time. 

e.

Deliver the results generated by virtue of this agreement, specifying the times that were expended for each of the tests to be conducted during the entire project. 

f.

Utilize specially-trained personnel to fulfill with specificity the activities of this project. 

g.

Maintain the necessary flexibility as activities arise during the duration of the Project, as long at it is requested in writing.

h.

Execute the corresponding Donation Contract, pertaining to the equipment indicated in section “b” of the Third Clause herein. 

THIRD: “APPLIED’S” COMMITMENTS

For the adequate fulfillment of the purpose of this Agreement, “APPLIED” commits itself to: 

a)

Finance the project for a minimum period of 24 months subject to extensions covering the following items:

-Consumables and Reagents.

-Deliver to UNAM the equivalent of three times the minimum monthly salary for México City, as additional remuneration for each technician that participates en the development of the research during the term of the current agreement with respect to that which was established Article 38 del Regulations Over Extraordinary Income of the UNAM. 

-Expenses Relating to Field Work.

-Operating Expenses (derived from receipt and delivery of samples).

b)

Donate to “LA UNAM” an ULTRA-FREEZER and a PERKIN ELMER/APPLIED BIOSYSTEM ABI PRISM 7700 SEQUENCE DETECTOR GENEAMP PCR INSTRUMENT SYSTEM.  The former will be delivered no more than 30 days after the signing of this agreement, and the latter no more than 6 months from the date on which this agreement is signed, and the prior use of this equipment is offered for its optimal use in “APPLIED’S” facilities in Apodaca, Nuevo León. This equipment will benefit the adequate development of the Project in the PATHOLOGY AREA OF USEDICO, C.E.I.E.P.A.A., TEQUISQUIAPAN. 

c)

“APPLIED” will proceed to effectuate in its facilities the diagnostic testing for Johne’s Syndrome (Paratuberculosis) and, based on that, establish comparative analyses of the results obtained by one party or the other.

d)

Maintain the necessary flexibility consistent with the activities and necessities that will emerge throughout the duration of this Project, as long as it is requested in writing. 

e)

Effectuate the expenses stemming from the receipt and delivery of samples. 

FOURTH: MANAGING COMMISSION

To facilitate the adequate fulfillment of the material objectives of this instrument, both parties agree to form a Managing Commission, consisting on one representative of each party, and that purpose designate: 

For “LA UNAM”, Dr. Gilberto Chávez Gris, Professor in the Pathology Department of USEDICO, C.E.I.E.P.A.A., Tequisquiapan, in the School of Veterinary Medicine, who will serve as the technical liaison between the parties. 

For “APPLIED”, Dr. Felipe Antonio Villanueva Zavala, who will serve as the technical/administrative liaison between the parties. 

FIFTH:  FUNCTION AND DUTIES OF THE MANAGING COMMISSION

Both parties agree that the aforementioned Managing Commission will have the following duties: 

a)

Regulate, supervise, and evaluate the activities of this instrument. 

b)

Resolve disagreements that might arise regarding the interpretation and compliance of said instrument. 

c)

Take or consider, depending on the circumstances, the pertinent complimentary agreements.

SIXTH: LABOR RELATIONS

The parties agree that personnel provided by each party in furtherance of the fulfillment of this agreement will be deemed to be employed only by the party that hired him or her. Therefore, each party will take responsibility for the conduct of its personnel, and under no circumstances will they be considered co-employers or substitute employers. 

SEVENTH:  SOCIAL RESPONSIBILITY

It is expressly agreed that neither party will be civilly liable for damages that could be caused administrative or academic work stoppages, or by acts of God or “force majeure”, or by unforeseeable events by virtue of which they might be blocked from complying with the obligations and objectives stemming from this Agreement. 

 

The parties expressly agree that if one or more instances of force majeure or some unforeseeable event were to occur, and if said instances were to take on such characteristics, or if they were of such severity or permanency, that they were to make it impossible to comply with this Agreement, the Parties should come to an agreement regarding its amendment.  

 

EIGHT: PUBLICATIONS

The researchers that will participate in the work made the subject of this Agreement will be able to publish findings of academic interest stemming from their work, as long as they have the express written authorization from both parties herein, and on the condition that the corresponding contribution of both parties will be recognized.

 

In the event findings to be published are considered to be of commercial interest, then the researchers cannot move forth to divulge the findings until the technology used for the development of said findings has been duly protected. 

NINTH: RIGHTS TO INTELLECTUAL PROPERTY

Both parties agree that findings that could conceivably be protected as being Intellectual and/or Industrial Design Property derived from work fulfilled under this Agreement will belong to the Party whose personnel did the work that is made the subject of publication, giving due recognition to those who participated in its development.  If the achievement was the product of a joint effort, both parties will share the ownership of the corresponding rights.  It is expressly understood that “LA UNAM” will be able to use the obtained results in the activities covered in this Agreement in furtherance of its academic work; and any and all publication stemming from this Agreement will be made from the corresponding information to the General Management of Legal Affairs.  

Both parties agree that all of the information compiled for and during the development of this experimental research will be absolutely confidential, and that it will be mutually exchanged between “LA UNAM” y “APPLIED” in writing, graphically, or verbally, including any and all registry data, technical knowledge, experience, standards, methods, tests, test results, design and manufacturing processes, quality control procedures, formulas, designs, packaging, photographs, drawings, sketches, specifications, risk analysis, storage information, computer programs, business forecasts, marketing information, sales and pricing, samples, and any other material that has or includes information relating to the products over the activities of each of the parties.  

 

THE PARTIES agree that any individual who participates in these studies will be subject to this Clause. 

“APPLIED” acknowledges that research results can be published, reporting the corresponding findings known to General Management of Legal Affairs, and agrees that “LA UNAM” will have authorization to print the results of the experimental research as part of the understanding. However, “APPLIED” will have received copies of any publication or proposed presentation at least sixty (60) days prior to the time when the publication or proposed presentation is submitted to a newspaper, editor, or other third-party. “APPLIED” will have this sixty (60) day period after receiving the aforementioned copies to object to said presentation or proposed publication, if it contains confidential information belonging to “APPLIED” or to protect the potential registration of any invention described therein.  

Any parties that intervene in the effectuation of the research commit and obligate themselves to refrain from divulging any type of information without express written consent of the pertinent counterpart. “APPLIED.”

 ELEVENTH: TERM

This Agreement will take effect from the date on which it is signed, and it will be in force for two (2) years. It is subject to extension for an additional two (2) years, contingent upon an evaluation of the results obtained, and the signing of a written agreement between the parties. 

TWELFTH: MODIFICATIONS

This Agreement can be amended or supplemented by mutual consent of the parties, and any such amendments or supplementation would bind the signatories from the date on which they are signed. 

THIRTEENTH:  ADVANCE TERMINATION

Either of the parties will be able to terminate this Agreement prior to its lapsing by way of written notice to its counterpart, by delivering such notification with ninety (90) days advance notice.  In such a case, both parties will take steps to avoid damages to each other or third-parties.  In the event of an early termination, “APPLIED” will cover the totality of any distributed costs, and the cost of work completed on behalf of “LA UNAM”.

In the same manner, this Agreement can be deemed terminated due to any breach on the part of either party of any the terms and provisions established herein, or due to circumstances, if this Agreement turns out to be an inefficient way of obtaining the results sought. 

The Managing Commission, to which this Agreement refers in the Fourth Clause, will determine the manner and terms of the termination, taking the necessary measures to avoid damages to either party, or to third-parties.  

FOURTEENTH: INTERPRETATION AND DISPUTES 

Both parties agree that any disputes that might arise regarding the interpretation and fulfillment of this Agreement will be resolved by the Managing Commission to which this Agreement refers in the Fourth Clause.

In the event the Parties were to be unable to amicably come to terms regarding such issues, the Parties agree that these issues will be subjected to the jurisdiction of the Federal Courts of Mexico City, hereby waiving any jurisdictional issues that might arise due to either Party’s present or future residency, or for any other circumstances that might be applicable.  

Having read this instrument, and fully understanding its content and scope, the Parties are signing it in quadruplicate en Mexico City, Federal District, on the 15th day of March , 2012.    

		
	FOR “LA UNAM”:

___________________________

DR. EDUARDO BÁRZANA GARCÍA,

SECRETARY GENERAL

	FOR “APPLIED”:

______________________________

DR. ANTONIO MILICI, PRESIDENT

	

___________________________

DR. FRANCISCO JOSÉ TRIGO TAVERA,

DIRECTOR OF THE VETERINARY MEDICINE SCHOOL

	 

	

___________________________

DR. GILBERTO CHÁVEZ GRIS,

PROFESSOR OF PATHOLOGY OF USEDICO, C.E.I.E.P.A.A., VETERINARY MEDICINE SCHOOL

	 

Page 1 of 7Converted by EDGARwiz

EMPLOYMENT AGREEMENT

EMPLOYMENT AGREEMENT (the “Agreement”), dated as of the 8th day of January 2012, between GeneThera, Inc. with address at 7577 W. 103rd Ave. Suite 212, Westminster, Colorado 80021 (the “Employer”) and Tony Milici, M.D., Ph.D., with address at 13589 Via Varra Road, Apartment 4302, Broomfield, Colorado 80020 (the “Employee”).

RECITALS:

A.

The Employer and its affiliates desire to employ the Employee.

B.

The Employee desires to be so employed upon the terms and conditions below set forth.

NOW, THEREFORE, in consideration of the terms and the mutual undertakings contained herein, it is agreed as follows:

1.

Term.

Subject to the terms of this Section 1 and Sections 7, 8, and 9, this Agreement shall commence  on January 8th, 2012 and expire on January 31, 2017 (the date on which this Agreement shall expire, as such date may be extended in accordance with the terms of this Section 1 is hereinafter referred to as the “Expiration Date”).  Subject to the terms of Section 7, 8 and 9, unless either party gives written notice to the other of its desire to terminate this Agreement at least thirty days prior to the then current Expiration Date or Extended Period (the “Termination Notification Date”), this Agreement will be automatically extended for further period(s) of two years from the then current Expiration Date (the “Extended Period”) on the same terms and conditions as herein set forth. Except when the contrary is indicated, the phrase “the term of this Agreement” shall henceforth be deemed to include the Extended Period. 

2.

Employment.  The Employer agrees to employ the Employee as the Company’s Chairman and Chief Executive Officer, GeneThera, Inc. the Employee accepts such employment.

3.

Duties.

(a)

The Employee shall render all services of the nature of the services as a Chief Executive Officer of GeneThera, Inc., and as a Chairman and Chief Scientific Officer, GeneThera, Inc., would render to a company in the biotechnology area.

(b)

During the term of this Agreement, Employee shall devout his full time, energy, skill and best efforts to promote Employer’s business and affairs and to perform his duties hereunder.

(c)

The Employee shall report directly to the Board of Directors of the Company.

1.

Compensation.  The Company shall pay to the Employee for the loyal and consistent services provided to it hereunder, a fee at the rate of $18,000 per month during the term of this Agreement; $216,000 per annum during the term of this Agreement.  Onetime payment of $24,000 shall be paid to Employee at the renewal of this agreement. Every March of every year during the five (5) year Agreement, Employee shall receive $90,000 Restricted Preferred B Stock. Annual compensation shall be determined for appropriate increases at the end of each year. Employee shall also receive bonus compensation or a lump sum equal to Two (2) times the salary at the time the company has the net income of Two Million ($2,000,000) Dollars each year based on performance. The Compensation Committee who shall hire a salary expert to determine comparable salary in the industry.

2.

Insurance and Benefits.  During the term of this Agreement, the Employee shall be entitled to participate in all employee benefit plans and insurance programs, including company vehicle, which shall be provided from time to time by the Employer to its employees (collectively, “Employee Benefit Plans”) in accordance with their terms and conditions.

3.

Termination.  This Agreement may be terminated by the Employer for Cause immediately upon written notice to the Employee. The term “Cause”, as used herein, shall mean the loss of any license necessary for the Employee to perform his duties hereunder, or any willful misconduct, malfeasance, gross negligence or other like conduct adversely affecting the best interests of the Employer, including, without limitation, (i) the failure or neglect by the Employee to perform his duties hereunder, (ii) the violation or attempted violation of any provision hereof, (ii) the commission of any felony, including, without limitation, any fraud against the Employer, any of its affiliates, clients or customers of the Employer.

4.

Return of Documents.  On termination of this Agreement or at any time upon the request of the Board of Directors of the Company or its affiliates, the Employee shall return to the Employer all documents, including all copies thereof, and all other property relating to the business or affairs of the Employer, including, without limitation, customer lists, agents or representatives lists, commission schedules and information manuals, letters, materials, reports, lists, and records (all such documents and other property being hereinafter referred to collectively s the “Materials”), in his/her possession or control, no matter from whom or in what manner he may have acquired such property. The Employee acknowledges and agrees that all of the Materials are property of the Employer and releases all claims of right of ownership thereto. 

5.

Confidentiality.

a)

Employee acknowledges he/she will have access to operating, financial, and other information of Employer and customers of the Employer including, without limitation, procedures, business strategies, and prospects and opportunities, techniques, methods, and information about, or received by it, from its customers and that divulgence will irreparably harm the Employer (“Confidential Information”). Employee also acknowledges that the foregoing provides Employer with a competitive advantage (or that could be used to the disadvantage of the Employer by a competitor). Employee also acknowledges the interest of the Employer in maintaining the confidentiality of such information and Employee shall not, nor any person acting on behalf of Employee, divulge, disclose or make known in any way or use for the individual benefit of Employee or others any of such Confidential Information. The foregoing is not applicable to such of the Confidential Information that is established by Employee to be in the public domain otherwise than as a result of its unauthorized disclosure by Employee or any other person.

b)

The customers of the Employer entrust the Employer with responsibility for their business in the expectation that the Employer will hold all such matters, including in some cases the fact that they are doing business with the Employer and the specific transactions in which they are engaged, in the strictest confidence (“Customer Confidences”). Employee covenants that after the termination of his employment with the Employer, he/she will hold all Customer Confidences in a fiduciary capacity and will not directly or indirectly disclose or use such information.

c)

Employee hereby assigns to the Employer his entire right, title, and interest in any idea, concept, technique, invention, and related documentation, other works of authorship, and the like (all hereinafter called “Developments”) made, conceived, written, or otherwise created solely by him/her while in the employment of the Employer or jointly with others, while in the Employment of the Employer, whether or not such Developments are patentable, subject to copyright protection or susceptible to any other form of protection which relate to the actual business or research or development of the Employer – Employee, after the termination of its employment with Employer, shall return to the Employer (and shall not retain any copies or excerpts therefrom) all documents, notes, analyses or compilations, including all copies thereof, and all other property relating to the Employer (“Employer Documents”) including, but not limited to, documents generated by Employee pursuant to his relation with the Employer.

d)

Employee acknowledges that the Employer has a compelling business interest in preventing unfair competition stemming from the use or disclosure of Customer Confidences and Confidential Information in the event that, after any termination on the post-employment activities of Employee, Employee goes to work or becomes affiliated with a competitor of the Employer.

e)

Employee further acknowledges that all customers he services or dealt with while employed with the Employer are customers of the Employer and not Employee’s personally. Employee also acknowledges that, by virtue of his employment with the Employer, Employee has gained or will gain knowledge of the identity, characteristics and preferences of the customers of the Employer, and that Employee will not use such Customer Confidences and Confidential Information at any time.

1.

Covenants Not to Compete or Solicit.

a)

The Employee undertakes that during the term of this Agreement and for 12 months thereafter, he/she will not, directly or indirectly (whether as sole proprietor, partner, stockholder, director, officer, employee or in any other capacity as principal or agent) compete with, or participate in any business that competes with, the Employer; provided that the Employee may invest in (i) the securities of any business or enterprise (but without otherwise participating in the activities of such business or enterprise) which are listed on a national or regional securities exchange or traded in the over-the-counter market, and (ii) equity interests of the Employer, of any member thereof.

b)

The Employee undertakes that during the term of this Agreement and for a period of 12 months thereafter he/she will not, directly or indirectly (whether as a sole proprietor, partner, stockholder, director, officer, employee or in any other capacity as principal or agent), do any of the following:

i.

Hire, or attempt to hire for employment, any person who is an employee of the Employer on the date of such termination of employment, or attempt to influence any such person to terminate his employment by the Employer; or

ii.

In any other manner interfere with, disrupt or attempt to disrupt the relationship; contractual or otherwise, between the Employer and any of its employees, or disparage the business or reputation of the Employer to any such person.

c)

The Employee undertakes that during the term of this Agreement and for 6 months thereafter he/she will not, directly or indirectly (whether as a sole proprietor, partner, stockholder, director, officer, employee or in any other capacity as principal or agent), do any of the following:

i.

Solicit, service or accept any actual or prospective accounts, clients or customers of the Employer during the period of the Employee’s employment by the Employer;

ii.

Influence or attempt to influence any of the accounts, customers or clients referred to in Subsection 9(c)(i) to transfer their business or patronage from the Employer to any other person or company engaged in a similar business.

iii.

Directly assist any person or company soliciting, servicing or accepting any of the accounts, customers or clients referred to in Subsection 9(c)(i); or 

iv.

In any other manner directly interfere with, disrupt or attempt to disrupt the relationship, contractual or otherwise, between the Employer and any of its accounts, customers or clients referred to in Subsection 9(d)(i), or any other person, or disparage the business or reputation of the Employer to any such person.

d)

The Employer undertakes that during the term of this Agreement and for a period of 30 months thereafter he will not, directly or indirectly, disparage the business or reputation of the Employee to any accounts, customers or clients referred to in Subsection 9(c)(i), or any other person.

1.

Enforcement of Covenants.  The parties acknowledge and agree that the covenants contained in Sections 8 and 9 are essential elements of this Agreement and that, but for the agreements of the Employee to comply with such covenants, the Employer would not have entered into this Agreement. The parties further acknowledge and agree that a breach by the Employee of the covenants contained in Sections 8 and 9 may result in irreparable injury to the Employer for which there is no adequate remedy at law and the Employer shall be entitled to seek enforcement of the same by means of a temporary restraining order and/or a preliminary or permanent injunction issue by the any court having jurisdiction thereof. In the event that the Employee breaches any of the covenants contained in Sections 8 and 9, the Employer shall be entitled to an accounting and repayment of all profits, Commissions and benefits the Employee receives in connection with such breach. The Employee agrees to indemnify and hold harmless the Employer against all its costs and expenses (including, without limitation, reasonable attorneys fees and expenses) incurred in connection with the enforcement of the covenants contained in Sections 8 and 9, except, with respect to the enforcement of any such covenant by the Employer, to the extent that the Employer is the prevailing party in any action or proceeding commenced by the Employer in connection therewith.  The covenants contained in Sections8 and 9 shall survive the termination of this Agreement. The remedies provided in this Section 10 shall be in addition to, and not in lieu of, any other remedies and relief including damages to which the Employer may be entitled.

2.

Blue-Pencil.  If any court of competent jurisdiction shall at any time deem the term of any of the covenants and undertakings of the Employee under Sections 8 and 9 herein too lengthy, the other provisions of those Sections 8 and 9 shall nevertheless stand, the period of restriction shall be deemed to be the longest period permissible by law under the circumstances. The court in each case shall reduce the period of restriction to permissible duration.

3.

Notices.  Unless otherwise specifically provided herein, all notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given if delivered by hand or mailed, certified or registered mail, return receipt requested , with postage prepaid at the following addresses, and/or to such other addresses and/or persons which either party may designate by like notice:

(a)

If to the Employee, to:

Tony Milici, M.D., Ph.D.

13589 Via Varra Road

Apartment 4302

Broomfield, CO  80020

(b)

If to the Employer, to:

Attn: Board of Directors

GeneThera, Inc.

7577 W. 103rd Ave. 

Suite 212

Westminster, CO  80021

With a copy to:

David Loev, Attorney

The Loev Law Firm, P.C.

6300 West Loop South

Suite 280

Bellaire, TX  77401

Office: 713-524-4110

Fax: 713-524-4122

1.

Governing Law.  This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of Colorado without regard to conflict of law provisions. Any disputes with respect to the interpretation of this Agreement or the rights and obligations of the parties hereto shall be exclusively brought in any federal or state court of competent jurisdiction located in the City of Denver, State of Colorado. Each of the parties waives any right to object to the jurisdiction or venue of such courts or to claim that such courts are an inconvenient forum.

2.

Additional Provisions.

(a)

This Agreement shall inure to the benefit of, and be binding upon, the Employer, its successors and assigns and shall inure to the benefit of, and be binding upon, the Employee, his executors, administrators, and heirs. The Employee may not assign or delegate the performance of any of his rights and/or obligations under this Agreement.

(b)

This Agreement constitutes the entire Agreement, representation and understanding of the parties hereto with respect to the subject matter hereof, and no amendment or modification hereof shall be valid or binding unless made in writing and signed by the parties hereto.

(c)

No waiver of any provision of this Agreement shall be valid unless the same is in writing and signed by the party against whom it is sought to be enforced. No waiver of any default or breach of this Agreement shall be deemed a continuing waiver or a waiver of any other breach or default.

(d)

Employee acknowledges that prior to the execution of this Agreement he had full opportunity to consult with his independent attorneys and advisors as he deemed appropriate and he fully understands the nature and scope of his rights and obligations hereunder.

(e)

If any provision of this Agreement is invalid or unenforceable in any jurisdiction such provision shall, as to such jurisdiction, be ineffective to the extent of such invalidity or unenforceability, but the foregoing shall not render invalid or unenforceable in such jurisdiction the remainder of this Agreement or the remainder of such provision or affect the validity or unenforceability of any provision of this Agreement in any other jurisdiction.

(The Remainder of this Page Left Intentionally Blank)

IN WITNESS WHEREOF, the parties have executed this Agreement or caused this Agreement to be executed on the date first above written.

GENETHERA, INC., “EMPLOYER”

_______________________________

Tannya L. Irizarry

Secretary, Board of Directors

By: Resolution of Board of Directors

TONY MILICI, “EMPLOYEE”

_______________________________

Tony Milici, M.D., Ph.D.; Individually

Employee Agreement Dr. Milici.doc

Page 1 of 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}]]